MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

People who trust doctors were more likely to get a COVID-19 vaccine and booster. Trust in public officials did not have the same effect.

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

An expert has answers for you about the latest COVID variant, JN.1, including information about tests, vaccines, and more.

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022,

Administering a COVID-19 vaccine as a nasal spray, rather than as an injection, may increase the vaccine’s overall effectiveness.

An unexpected case of rabies found in an animal can raise concerns for a potential outbreak. Proactive vaccination of both wildlife and people can help protect everyone.

The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.